Risedronate in Osteopenic Postmenopausal Women

NCT00345644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: risedronate
DRUG: risedronate placebo

Sponsor

Sanofi

Collaborators

[object Object]